From professional translators, enterprises, web pages and freely available translation repositories.
hypophysitis
hypophysite
Last Update: 2014-12-09
Usage Frequency: 13
Quality:
lymphocytic hypophysitis
hypophysite lymphocytaire
Last Update: 2014-12-09
Usage Frequency: 12
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
hypophysitis (disorder)
hypophysite
Last Update: 2014-12-09
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
lymphocytic hypophysitis (diagnosis)
hypophysite lymphocytaire
Last Update: 2014-12-09
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
hypopituitarism (including hypophysitis)c, hypothyroidismc
hypopituitarisme (y compris hypophysite)c, hypothyroïdiec
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hypophysitis resolved in 7 patients, 2 with sequelae.
l’hypophysite s’est résolue chez 7 patients, 2 avec des séquelles.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hypophysitis (1 grade 1; 1 grade 2, and
une hypophysite (1 de grade 1 ; 1 de grade 2 ; et 3 de grade 3), une insuffisance surrénale (1 de grade 1 ; 5 de
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
symptomatic grade 2 or 3 hypothyroidism, hyperthyroidism, hypophysitis,
hypothyroïdie, hyperthyroïdie, hypophysite symptomatiques de grade 2 ou 3,
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
adrenal insufficiency, hypopituitarism, hypophysitis, thyroiditis, diabetic ketoacidosis
insuffisance surrénale, hypopituitarisme, hypophysite, thyroïdite, acidocétose diabétique
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
adrenal insufficiency, hypopituitarism, hypophysitis, hyperthyroidism, thyroiditis, hyperglycaemiab
insuffisance surrénale, hypopituitarisme, hypophysite, hyperthyroïdie, thyroïdite, hyperglycémieb
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hypophysitis led to discontinuation of pembrolizumab in 4 (0.1%) patients.
une hypophysite a conduit à un arrêt de pembrolizumab chez 4 (0,1 %) patients.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hypophysitis has been reported in patients receiving pembrolizumab (see section 4.8).
des cas d’hypophysite ont été rapportés chez des patients recevant pembrolizumab (voir rubrique 4.8).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
there were no reports of hypophysitis, diabetes mellitus, or diabetic ketoacidosis in these studies.
il n'a pas été rapporté de cas d'hypophysite, de diabète sucré ou d’acidocétose diabétique dans ces études.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
for symptomatic hypophysitis, nivolumab should be withheld, and hormone replacement should be initiated as needed.
en cas d'hypophysite symptomatique, nivolumab doit être suspendu, et un traitement substitutif hormonal doit être débuté, si nécessaire.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
for symptomatic grade 2 or 3 hypophysitis, nivolumab or nivolumab in combination with ipilimumab should be withheld, and hormone replacement should be initiated as needed.
en cas d'hypophysite symptomatique de grade 2 ou 3, nivolumab ou nivolumab en association à l’ipilimumab doit être suspendu, et un traitement substitutif hormonal doit être débuté, si nécessaire.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
patients should be monitored for signs and symptoms of hypophysitis (including hypopituitarism and secondary adrenal insufficiency) and other causes excluded.
les patients doivent être surveillés pour rechercher les signes et symptômes d’une hypophysite (y compris un hypopituitarisme et une insuffisance surrénalienne secondaire) et les autres causes doivent être éliminées.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
severe endocrinopathies, including hypothyroidism, hyperthyroidism, adrenal insufficiency, hypophysitis, diabetes mellitus, and diabetic ketoacidosis have been observed with nivolumab treatment.
des endocrinopathies sévères, incluant hypothyroïdie, hyperthyroïdie, insuffisance surrénale, hypophysite, diabète, et acidocétose diabétique ont été observés avec le traitement par nivolumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
severe endocrinopathies, including hypophysitis (including hypopituitarism and secondary adrenal insufficiency), type 1 diabetes mellitus, diabetic ketoacidosis, hypothyroidism, hyperthyroidism and thyroiditis
endocrinopathies sévères incluant hypophysite (y compris hypopituitarisme et insuffisance surrénalienne secondaire), diabète de type 1, acidocétose diabétique, hypothyroïdie, hyperthyroïdie et thyroïdite
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
decreased secretion of hormones produced by adrenal glands (glands situated above the kidneys), underactive function (hypopituitarism) or inflammation (hypophysitis) of the pituitary gland situated at the base of the brain, swelling of the thyroid gland, acid in the blood produced from diabetes (diabetic ketoacidosis)
diminution de la sécrétion des hormones produites par les glandes surrénales (glandes situées au-dessus des reins), diminution de l'activité (hypopituitarisme) ou inflammation (hypophysite) de l'hypophyse située à la base du cerveau, gonflement de la thyroïde, acidité dans le sang due au diabète (acidocétose diabétique)
Last Update: 2017-04-26
Usage Frequency: 1
Quality: